Medico Remedies enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
160————
3.83.82.51.50.9
18.818.814.78.19.8
175————
15.115.112.26.58.9
₹21.04————
94.394.377.060.453.6
20.0%20.0%19.1%13.3%18.2%
0.11×————
0.74×————
9.98×————
12.08×————
29.73×————
Reference items — trailing FY values
238206151145140
17.517.015.012.99.6
14.513.912.010.06.9
—5.94.92.48.2
5.95.94.92.48.2
—5.44.62.28.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

MEDICO₹19.22

Medico Remedies Limited

· Pharma & Health
₹ CrorePeersMEDICAMEQHALEOSLABSAAREYDRUGSNECLIFEALBERTDAVDVALIANTLABNATCAPSUQZIMLABMcap ₹160 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————159.5
- Cash, Equiv & ST Investments0.91.52.53.83.8
+ Total Debt9.88.114.718.818.8
Enterprise Value————174.6
Net Debt (memo)8.96.512.215.115.1
EV per Share————21.04
Total Capital53.660.477.094.394.3
Total Debt/Total Capital18.2113.3219.0919.9719.97
Total Debt/EV————0.11
EV/Sales————0.74
EV/EBITDA————9.98
EV/EBIT————12.08
EV/Free Cash Flow————29.73
Reference Items — Trailing FY Values
Sales140.4144.9150.9206.4237.5
EBITDA9.612.915.017.017.5
EBIT6.910.012.013.914.5
Operating Cash Flow8.22.44.95.9—
Free Cash Flow8.22.44.95.95.9
FCFF (free cash flow to the firm)8.22.24.65.4—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.